Cyclic Vomiting Syndrome
12
3
3
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
16.7%
2 terminated out of 12 trials
75.0%
-11.5% vs benchmark
8%
1 trials in Phase 3/4
83%
5 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome.
A Study of Auricular Neurostimulation for Children With Cyclic Vomiting Syndrome
Autonomic Reactivity and Personalized Neurostimulation
Auricular Neurostimulation for Cyclic Vomiting Syndrome
Cortical Excitability in Cyclic Vomiting Syndrome
Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome
Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis
Heartfulness Meditation (HFM) in Cyclic Vomiting Syndrome (CVS)
Effects of an Integrative Health Care Model With Meditation and Care Cordination in CVS
Applying Nutrient Drink Test in Understanding Pathophysiology of CVS
Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children
The Use of L-Carnitine And CoQ10 Supplements In the Treatment of Cyclic Vomiting Syndrome (CVS)